USRE42024E1 - Dental compositions - Google Patents

Dental compositions Download PDF

Info

Publication number
USRE42024E1
USRE42024E1 US11/320,560 US32056005A USRE42024E US RE42024 E1 USRE42024 E1 US RE42024E1 US 32056005 A US32056005 A US 32056005A US RE42024 E USRE42024 E US RE42024E
Authority
US
United States
Prior art keywords
composition
viscosity
treatment temperature
temperature
tooth structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime, expires
Application number
US11/320,560
Inventor
Matthew C. Trom
Joel D. Oxman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/190,717 external-priority patent/US6312667B1/en
Priority claimed from US09/190,541 external-priority patent/US6312666B1/en
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Priority to US11/320,560 priority Critical patent/USRE42024E1/en
Application granted granted Critical
Publication of USRE42024E1 publication Critical patent/USRE42024E1/en
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/20Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22Peroxides; Oxygen; Ozone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90Block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • This invention relates to dental compositions having viscosities capable of responding to a change in temperature.
  • the invention also relates to methods of applying the composition directly onto a target area of the substrate.
  • a dental coating composition is generally desirable for a wide variety of applications, such as etching or bleaching. To attain proper application at the desired location, it is desirable that the composition be controllable and slow to flow away from the target site. Thus a high viscosity dental composition in the oral environment would be quite useful.
  • compositions that have very low viscosities as well as compositions that are highly thickened and therefore possess high viscosity. Those with low viscosities are difficult to control and have tendencies to flow away from the target site once they are applied. Compositions with high viscosities are difficult to extrude through a small orifice.
  • Certain dental compositions may use thickeners such as fumed silica and polyvinyl alcohols. Problems encountered in using these thickeners include aging, which results in non-homogenous gels which make handling difficult, and shear thinning, which reduces the viscosity of a gel when extruded through an orifice and thinning at elevated temperatures. Thinning can result in a material that drips from the orifice and that may fail to remain localized at the desired point of application.
  • thickeners such as fumed silica and polyvinyl alcohols.
  • the present invention provides a dental composition suitable for application in the oral environment comprising a thermally responsive viscosity modifier that is capable of undergoing an increase in viscosity in response to an increase in temperature.
  • a thermally responsive viscosity modifier that is capable of undergoing an increase in viscosity in response to an increase in temperature.
  • These compositions also preferably have the ability to reverse their viscosity upon the lowering of temperature.
  • compositions of the invention work very well in the oral environment where temperature is generally higher than ambient or the pre-treatment temperature of a composition. This differential in temperature thickens the composition and thus provides a thickened, semi-solid or gel-like composition in the oral environment.
  • a preferred method of use of the invention comprises applying the composition directly onto the oral surface. Upon exposure of the composition to the oral temperature, the composition thickens to a semi-solid or gel-like state.
  • the present invention provides a method of applying a dental composition in the oral environment using a dental composition comprising about 10% by weight to about 50% by weight of a thermally responsive viscosity modifier and an adjuvant, wherein the composition is in a low viscosity state at a pre-treatment temperature and a highly viscous state at a treatment temperature that is higher than the pre-treatment temperature.
  • the method includes applying the composition through an orifice, preferably the orifice of a syringe, onto a surface, wherein the composition is at the pretreatment temperature and in the low viscosity state prior to being applied onto the surface, allowing the composition to warm to the treatment temperature and increase in viscosity to the highly viscous state wherein the viscosity of the composition at the treatment temperature is at least about 10 times the viscosity of the composition at the pre-treatment temperature, and allowing the composition to remain on the surface.
  • the pre-treatment temperature is at most about room temperature and the treatment temperature is about body temperature.
  • Preferred adjuvants include acids, whitening agents, fluoride, anti-microbial agents, and medicaments.
  • FIG. 1 is a graphic illustration of the viscosity versus temperature data as described in Example 1.
  • FIG. 2 is a graphic illustration of the viscosity versus temperature data as described in Example 7.
  • the present invention provides a dental composition in a low viscosity state prior to application onto an oral surface, but which also is highly viscous, thick and controllable at the target site. These compositions are easily dispensed, applied, and manipulated when handled by the user, and are easily controlled upon application to the target site. Because the composition has a low viscosity initially at a pre-treatment temperature, it requires lower syringe extrusion forces to deliver the compositions to the intended site. In turn, this would allow a user the alternative of using a brush or other applicator to apply the composition. In addition, production of low viscosity compositions may provide easier processing and greater uniformity and consistency.
  • compositions of this invention are particularly suitable for use in the intraoral environment where a composition having a pre-treatment temperature at or lower than ambient (room temperature) is applied to a user's oral surface that is near or at oral temperature of about 30° C. to about 39° C.
  • room temperature ambient
  • the composition be thermally reversible.
  • the composition not only has the ability to increase its viscosity at an elevated intra-oral temperature, but also reverses or decreases its viscosity upon a decrease in temperature.
  • the capacity of the dental composition to thicken at oral temperatures is a critical feature of the invention, for it is in this property that many of the disadvantages of previous approaches are overcome.
  • the dissipative characteristic of liquid solutions is avoided since the compositions herein experience thickening at the site of treatment.
  • the problems of formulation, handling, delivery and application of viscous compositions are overcome since the present compositions may be free-flowing liquids prior to treatment.
  • etching hard tissue typically requires etching a target site or controlled areas of several teeth at one time.
  • Current etchant liquids are easy to dispense and apply, but these tend to flow away from the target area of application. Consequently, an etch patch could be larger than desired or, more undesirably, contact with the soft tissue could occur, which can cause sensitivity or irritation.
  • a large etch patch unnecessarily increases the risk of decalcification during treatment.
  • a “semi-solid,” as used herein, is a material whose physical state is between the solid and liquid state, in which pure or mixed solvent or solution is entrained within a network, and can alternatively be considered a gel.
  • pure or mixed solvent and/or solution as stated herein, it is recognized that a mixture of solvents may be absorbed by the network. Additionally, the solvent may include salts or other additives so as to form a solution, which may also be absorbed or entrained within the network.
  • Thickening as used herein, is where a composition undergoes a substantial increase in the viscosity of the composition. The degree of thickening is dependent on the initial viscosity of the composition.
  • the initial viscosity of the composition may be low enough such that the composition is in a liquid state. Subsequently, upon exposure to a temperature of about near or at oral temperature, the viscosity increases to result in a thickened composition.
  • a viscosity increase in the range of about 10- to about 100-fold can be experienced when the initial viscosity is such that the composition is a liquid.
  • a composition in a liquid state may have a viscosity of about 0 to about 7000 poise.
  • the viscosity of the composition can increase to at least about 10,000 poise.
  • the composition preferably has the ability to reverse its viscosity and return to flow properties of a liquid.
  • Yet another preferred embodiment of the invention is when the initial viscosity of the composition is at a level at which the composition is in a semi-solid state at pre-treatment temperature (viscosity is at least about 5000 poise), and upon exposure to a higher treatment temperature, the composition transforms into an “ultra-thick” composition or one with a substantially higher viscosity and very low flow characteristics.
  • the degree of thickening is typically about 2- to about 5-fold.
  • the pre-treatment temperature is the temperature at which the composition is subjected to prior to application or treatment.
  • the range for the pre-treatment temperature can be about 5° C. to about 29° C., although there may be certain instances where the temperature may be outside this range. Having a pre-treatment temperature at about 20° C. to about 25° C. allows the composition to be easily stored at ambient or room temperature. Alternatively, the compositions of the invention can also be advantageously stored at lower, refrigeration pre-treatment temperatures of about 5° C. to about 10° C. to provide improved stability and shelf life.
  • the treatment temperature is the temperature at which the composition is exposed during intraoral application. This can be at or near body temperature, or about 30° C. to about 39° C.
  • the dental composition consists of a water-miscible, physiologically compatible medium that is liquid at ambient temperature below about 30° C. and experiences thickening at oral temperatures above about 30° C. It has been found that a composition having a thickening transition temperature in the range of from about 25° C. to about 40° C. is useful in the practice of the present invention. Preferably, the thickening occurs in a temperature range of from about 25° C. to about 39° C., and more preferably from about 30° C. to about 35° C.
  • compositions of this invention are comprised of a solvent and one or more polymeric substances that provide the desired viscosity increase at the desired elevated temperature range in the said composition.
  • adjuvants may be added to the composition.
  • the composition of this invention should be physiologically compatible so that no adverse reaction occurs if the dental composition comes in contact with human tissue or fluids.
  • a “thermally responsive viscosity modifier” is one or more polymeric substances that provide the composition or polymeric system the capability of substantially changing its viscosity in response to a change in temperature.
  • Suitable polymeric substances useful as thermally responsive viscosity modifiers include polyoxyalkylene polymers, particularly the polymeric surfactants available under the tradename PLURONIC. This class of polymers is available commercially from BASF Wyandotte Corporation. Other polyoxyalkylene polymers may also be useful as a thermally-responsive composition material.
  • a preferred dental composition in accordance with this invention comprises an aqueous solution of a selected polyoxyethylene-polyoxypropylene block copolymer.
  • a composition comprising polyoxyethylene-polyoxypropylene block copolymers in which the number of polyoxyethylene units is at least about 50% of the number of units in the total molecule, and the block copolymer having an average molecular weight of from about 1100 to about 15,500 has been found to be particularly useful. It is more preferable that a composition comprises about 70% polyoxyethylene units of the total number of monomeric units in the copolymer and the copolymer has an average molecular weight of about 11,500.
  • PLURONIC F-127 is a material that meets these criteria.
  • the PLURONIC polymers are closely related block copolymers that may be generically classified as polyoxypropylene-polyoxyethylene condensates that terminate in primary hydroxyl groups. These polymers are formed by the condensation of propylene oxide into a propylene glycol nucleus followed by the condensation of ethylene oxide onto both ends of the polyoxypropylene base.
  • the polyoxyethylene hydrophilic groups on the ends of the base pre-polymer are controlled in length to constitute from about 10% to about 80% by weight of the final polymer.
  • the PLURONIC polymer series of products may be represented empirically by the formula: HO(C 2 H 4 O) a (C 3 H 6 O) b (C 2 H 4 O) c H where a and c are statistically equal.
  • the concentration of the block copolymers is an important parameter and can be formulated in such a manner corresponding to the other components' concentrations.
  • concentration of the copolymer By adjusting the concentration of the copolymer to accommodate other solutes present in the composition, any desired liquid to semi-solid transition temperature in the critical range of above ambient temperature and below body temperature can be achieved.
  • the principal consideration is the selection of a concentration that, in conjunction with all of the constituents of the total composition, will provide a liquid to semi-solid transition temperature in the required range.
  • a useful block copolymer concentration is from about 5% to about 40% by weight (wt. %) of the composition, particularly from about 15 wt. % to about 26 wt. % of the composition. Excellent results have been obtained using aqueous solutions having from about 17 wt. % to about 29 wt. % of PLURON 1 C F-127. Increased polymer concentrations may be required in highly acidic systems to affect the same results as in a less acidic system so that, in optimizing the thickening or gelation characteristics for a system, the pH of the solution must be taken into account.
  • Particularly preferred polymers for the present invention are the PLURONIC F-127 and F-108.
  • These viscosity modifiers are block copolymers of ethylene oxide and propylene oxide. Thickening tendencies of block copolymers increase as ethylene oxide content and total molecular weight increase.
  • Thermally responsive block copolymers have been disclosed in U.S. Pat. Nos. 4,474,751; 4,474,752; 5,441,732; and 5,252,318, as well as the Product Catalog, “BASF Performance Chemicals,” all the teachings of which are incorporated by reference herein. These block copolymers offer extremely low toxicity and a high degree of mildness for applications involving human contact.
  • a preferred solvent for the composition of this invention is water.
  • the concentration of water in the composition can be in the range of from about 30 wt. % to about 90 wt. % of the composition.
  • water can exist in the range of about 40 wt. % to about 80 wt. % of the composition.
  • the water used in forming the aqueous solution is preferably purified, as by distillation, filtration, ion-exchange, or the like.
  • Co-solvents may be used, including anhydrous solutions comprising a polyol component such as propylene glycol or polyethylene glycol. Glycerin may also be used as a constituent of the composition.
  • Adjuvants can be added to the composition for various purposes (e.g., acids for dental etchants and whitening agents for dental whiteners).
  • a preferred embodiment of the invention can contain fluoride, a desirable additive in the oral composition.
  • Additives may also be included in the composition to promote the stability of the formulation.
  • Anti-microbial agents, anti-fungal agents, and preservatives may be added to the composition to improve shelf-life.
  • the compositions may further include other adjuvants such as medicaments, indicators, dyes, wetting agents, buffering agents, thixotropes, polyols and the like, contingent upon attainment of the desired degree of etching performance and suitability for use on the desired hard tissue.
  • a composition may contain indicators that communicate to the user the degree of etching that has been performed on the hard tissue.
  • the compositions may further include other adjuvants such as fillers, cariostatic agents and flavorings.
  • acids may be added to the composition as an adjuvant.
  • Acids for use in the present invention can be inorganic or organic acids, and if organic can be monomeric, oligomeric or polymeric.
  • a precursor to the acid such as an acid anhydride, e.g., 4-Methacryloxyethyl Trimellitate Anhydride (4-META), acid halide (including inorganic acid halides such as Lewis acids, e.g., ferric chloride, and organic acid halides), or ester can be used in place of the acid itself, e.g., to generate the desired acid in situ.
  • Suitable acids include mineral acids, carboxylic acids, sulfonic acids, and phenols, with carboxylic acids, alkylsulfonic acids, arylsulfonic acids, and phosphonic acids being preferred.
  • the acid has a pKa in water that is less than or equal to that of phenol.
  • the pKa of the acid is between about ⁇ 20 and about +10, more preferably between about ⁇ 10 and about +5.
  • the acid can be liquid or a solid; if a solid it should be dissolved in a suitable solvent to enable the acid to wet the hard tissue.
  • Liquid acids can also be dissolved in a suitable solvent, e.g., in order to facilitate wetting.
  • Preferred solvents for the acid are the film former cosolvents discussed in more detail below.
  • Suitable inorganic acids include hydrobromic acid, hydrochloric acid, nitric acid, phosphoric acid, and sulfuric acid.
  • Suitable organic acids include acetic acid, ⁇ -chloropropionic acid, 2-acrylamido-2-methylpropane sulfonic acid, acrylic acid, benzenesulfonic acid, benzoic acid, bromoacetic acid, 10-camphorquinone-sulfonic acid, 10-camphorsulfonic acid, chloroacetic acid, citraconic acid, citric acid, dibromoacetic acid, dichloroacetic acid, di-Hema ester of 1,2,4,5 benzenetetracarboxylic acid, 2,4-dinitrophenol, ethylenediaminetetraacetic acid (EDTA), the mono-, di- and trivalent salts of EDTA, formic acid, fumaric acid, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid, maleic acid, methacrylic acid, 2-n
  • the hard tissues that can be etched include human and animal tissues such as teeth, including the component parts which are enamel, dentin, and cementum.
  • the invention has particular utility for etching dentin, sclerotic dentin, enamel, and cervical enamel.
  • the etchant is permitted to stand on the hard tissue for a desired period of time, readily volatile cosolvents are removed therefrom (e.g., by air-drying) to modify the surface of the hard tissue.
  • Delivery of the etching composition of the invention may be performed in various methods. One method of delivery of the etching composition is the direct application of the composition onto the hard tissue.
  • compositions container or dispenser such as a bottle, vial, syringe, or tube.
  • a brush to paint or coat the composition onto the hard tissue.
  • the composition is kept on the hard tissue for a desired period to effectuate etching. The length of time the composition is in contact with the hard tissue would depend on the amount of etching desired.
  • a preferred method of use comprises first etching with the composition of the present invention, followed by an application of a dental material on the tissue such as a sealant or coating, restorative material, adhesive, cement, dental primer or film former.
  • a dental material on the tissue such as a sealant or coating, restorative material, adhesive, cement, dental primer or film former.
  • Yet another preferred method is first etching with the composition of the present invention, then followed by an application of a bonding agent for purposes of bonding an orthodontic appliance onto a tooth.
  • the invention enables etching of hard tissue in order to improve the bond strength or durability of a restorative or coating applied thereto.
  • Hard tissue to which the etchant is applied preferably is first cleaned using conventional methods (e.g., by abrading it with a bur), rinsed (e.g., using water) and dried (e.g., using air).
  • a conventional basing material e.g., calcium hydroxide or a glass ionomer cement.
  • the acid should be allowed to stand on the surface of the hard tissue long enough to provide the desired degree of etching.
  • the standing time will depend upon the particular acid employed, the type of hard tissue and its intended use, and the time available for carrying out the etching procedure. For etching dentin and enamel, standing times less than about 5 minutes, and preferably about 5 seconds to one minute provide very effective etching, although shorter or longer times can be used if desired.
  • whitening agents may be added to the composition as an adjuvant.
  • the whitening agent used in the present invention may be any material that has the effect of whitening teeth.
  • Whitening agents are preferably selected from hydrogen peroxide and its urea complex: carbamide peroxide (CO (NH 2 ) 2 H 2 O 2 ). These whitening agents are also known by alternative names, including urea hydrogen peroxide, hydrogen peroxide carbamide, or perhydrol-urea.
  • sodium hypochlorite may be suitable for use as the whitening agent.
  • concentration of a whitening agent in the composition can vary depending upon its reactivity.
  • the currently preferred concentration range is from about 3% to about 40%, with a range from about 4% to about 21% being most preferred.
  • the currently preferred concentration range is from about 2% to about 10%.
  • whitening composition of this invention can be employed in using various methods.
  • One method of use of these whitening compositions entails application of the composition to the tooth structure directly from the composition's container or dispenser such as a bottle, syringe, or tube.
  • the whitening composition can be applied by using a brush to paint it onto the tooth surface.
  • the composition is kept on the user's tooth surface(s) for a desired time period to effectuate whitening. The length of time the composition is in contact with the tooth surface(s) would depend on the amount of discoloration the user prefers to remove.
  • the whitening composition is loaded into a dental tray.
  • dental trays can be custom fitted to a user's dentition and be made with or without reservoirs.
  • a preferred reservoir is described in U.S. Pat. No. 6,126,443.
  • Dental trays can be made from varying thicknesses and softness of pliable thermo-formable plastic materials. Typically, these materials are 0.02-0.08 inches thick.
  • An alternative method of use incorporates a pre-warmed dental tray into which the whitening composition is loaded. Upon contact of the composition having a pre-treatment temperature, with the tray having a higher temperature, the composition experiences thickening.
  • This method provides easy handling of a loaded tray into a user's mouth, with minimal fear of the composition moving to an undesired section of the tray or having the composition flow out of the tray.
  • the dental compositions are thermally reversible, the composition can be readily removed from the hard tissue by cooling the material below the liquid to semi-solid transition temperature, thus reversing the thickening effect. This can be accomplished with cool water or other physiologically compatible liquid.
  • the concentrations of the components in the composition may be adjusted and diluted by adding water or other liquid solution.
  • the transition temperature is correspondingly adjusted, and thus provides the user the ability to remove the composition even with warm solutions.
  • Water or other liquid solutions may be administered through a rinsing cup, squirt bottle, a liquid dispensing dental tool, or any other liquid dispensing device that can provide solution to the oral environment.
  • administering cool or cold water provides a significant decrease in viscosity.
  • the composition may be brushed, wiped, or blown off.
  • Etching compositions were made in which the acid used was 3M Etchant Liquid manufactured by 3M Dental Products Division. Sample compositions 2 through 7 were mixed such that the compositions contained 15-30% by weight of PLURONIC F127 (BASF) in 3M Etchant Liquid (3M Co., St. Paul, Minn.).
  • PLURONIC F127 BASF
  • compositions 1-7 are phosphoric acid gels of the following types:
  • compositions 2 and 7 were further tested using a laboratory convection oven, heated to a temperature of approximately 45° C.
  • the concentration of PLURON 1 C F127 had significant impact on the initial viscosity of the acid etchant gel as well as the temperature at which the acid formed an “immobile gel.”
  • An “immobile gel” indicates that the gel did not flow readily under its own weight in small volumes but was still able to be easily manipulated into new positions using hand-held dental instruments.
  • the composition that contained 15.3% PLURONIC F127 had a low initial viscosity similar to that of 3M Etchant Liquid and did not form an immobile gel at approximately body temperature but did form an immobile gel at approximately 45° C.
  • the composition containing 28.8% PLURONIC F127 was a thick liquid when cooled in a refrigerator at approximately 5° C., but was an immobile gel at room temperature of approximately 24° C.
  • the citric acid and phosphoric acid gels had similar initial viscosity and gel characteristics with significantly different levels of PLURONIC F127. More PLURONIC F127 is required in highly acidic systems to affect the same results as in a less acidic system so that, in optimizing the gelation characteristics for a system, pH of the stock etchant solution must be taken into account.
  • aqueous stock solution containing approximately 15% hydrogen peroxide was prepared by transferring 5 grams of a 30% H 2 O 2 (J. T. Baker) and 5 grams of distilled water to a glass vial. The stock solution was mixed thoroughly.
  • aqueous stock solution containing approximately 20% urea hydrogen peroxide (carbamide peroxide) was prepared by transferring 4 grams of 97% urea hydrogen peroxide (Sigma) and 16 grams of distilled water to a glass vial. The stock solution was mixed thoroughly. (The hydrogen peroxide content of the urea hydrogen peroxide was about 35%). Stock solution contained about 7% H 2 O 2 .
  • a thermally-reversible hydrogen peroxide composition was prepared by transferring the ingredients below to a glass vial and mixing thoroughly until a colorless and transparent liquid solution was obtained.
  • the liquid and semi-solid (gel) states were both semi-quantitatively evaluated for hydrogen peroxide utilizing hydrogen peroxide analysis strips.
  • the analysis utilized “EM Quant Peroxide Test Strips” (EM Science Gibbstown, N.J., Catalog No. 10011-1). The compositions were evaluated according to the manufacturer's directions.
  • a thermally reversible composition containing urea hydrogen peroxide was prepared by transferring the ingredients below to a glass vial and mixing thoroughly until a colorless and transparent liquid solution was obtained.
  • liquid and semi-solid states were both semi-quantitatively evaluated for hydrogen peroxide utilizing hydrogen peroxide analysis strips, EM Quant Peroxide Test Strips (EM Science; Gibbstown, N.J., Catalog No. 10011-1), according to the manufacturer's directions. Both the liquid and semi-solid states indicated the presence of significant amounts of available peroxide.
  • Table 1 summarizes the results of the two previous examples.
  • the “+” indicates an increase in the viscosity.
  • the presence of hydrogen peroxide as indicated in the table are the results obtained from the semi-quantitative test using the EM Quant Peroxide Test Strips and test method.
  • compositions have been evaluated for viscosity as a function of temperature.
  • the compositions are described below:
  • Samples were further evaluated for viscosity as a function of temperature between 15° C. and 45° C. utilizing a Rheometrics RDA II Rheometer. Complex viscosity, ⁇ * (units of measure is in Poise), versus temperature data were obtained using a controlled strain rheometer (“RDA2”, Rheometrics Scientific, Piscataway, N.J.). A parallel plate geometry was used with a plate diameter of 25 mm and a gap of approximately 1 mm. Samples were subjected to an oscillatory strain of 10% applied at a frequency of 1 rad/sec while the temperature was ramped from 15° C. and 45° C. (3° C./min).
  • RDA2 controlled strain rheometer
  • FIG. 2 illustrates that aqueous compositions containing PLURONIC F127 polymer exhibit a relatively sharp increase in viscosity upon warming from room temperature to about 45° C.
  • Sample C which exhibited semi-solid-like characteristics at room temperature (due to the incorporation of a fumed silica), also increased substantially upon an increase in temperature.

Abstract

Dental compositions containing adjuvants are provided that have the capability of undergoing an increase in viscosity in response to an increase in temperature. In a preferred embodiment, the compositions also have the ability to reverse their viscosity in response to a decrease in temperature.

Description

RELATED APPLICATIONS
This is a continuation-in-part of U.S. patent application Ser. Nos. 09/190,541 now U.S. Pat. No. 6,312,666 and 09/190,717, now U.S. Pat. No. 6,312,667 both filed Nov. 12, 1998, and both of which are incorporated herein by reference in their entireties.
FIELD OF THE INVENTION
This invention relates to dental compositions having viscosities capable of responding to a change in temperature. The invention also relates to methods of applying the composition directly onto a target area of the substrate.
BACKGROUND
In the dental art, the use of a dental coating composition is generally desirable for a wide variety of applications, such as etching or bleaching. To attain proper application at the desired location, it is desirable that the composition be controllable and slow to flow away from the target site. Thus a high viscosity dental composition in the oral environment would be quite useful.
Currently available dental compositions are provided in seemingly extreme viscosity states. That is, there exist compositions that have very low viscosities as well as compositions that are highly thickened and therefore possess high viscosity. Those with low viscosities are difficult to control and have tendencies to flow away from the target site once they are applied. Compositions with high viscosities are difficult to extrude through a small orifice.
Certain dental compositions may use thickeners such as fumed silica and polyvinyl alcohols. Problems encountered in using these thickeners include aging, which results in non-homogenous gels which make handling difficult, and shear thinning, which reduces the viscosity of a gel when extruded through an orifice and thinning at elevated temperatures. Thinning can result in a material that drips from the orifice and that may fail to remain localized at the desired point of application.
SUMMARY OF THE INVENTION
The present invention provides a dental composition suitable for application in the oral environment comprising a thermally responsive viscosity modifier that is capable of undergoing an increase in viscosity in response to an increase in temperature. These compositions also preferably have the ability to reverse their viscosity upon the lowering of temperature.
Compositions of the invention work very well in the oral environment where temperature is generally higher than ambient or the pre-treatment temperature of a composition. This differential in temperature thickens the composition and thus provides a thickened, semi-solid or gel-like composition in the oral environment.
A preferred method of use of the invention comprises applying the composition directly onto the oral surface. Upon exposure of the composition to the oral temperature, the composition thickens to a semi-solid or gel-like state.
In one aspect, the present invention provides a method of applying a dental composition in the oral environment using a dental composition comprising about 10% by weight to about 50% by weight of a thermally responsive viscosity modifier and an adjuvant, wherein the composition is in a low viscosity state at a pre-treatment temperature and a highly viscous state at a treatment temperature that is higher than the pre-treatment temperature. The method includes applying the composition through an orifice, preferably the orifice of a syringe, onto a surface, wherein the composition is at the pretreatment temperature and in the low viscosity state prior to being applied onto the surface, allowing the composition to warm to the treatment temperature and increase in viscosity to the highly viscous state wherein the viscosity of the composition at the treatment temperature is at least about 10 times the viscosity of the composition at the pre-treatment temperature, and allowing the composition to remain on the surface. Preferably the pre-treatment temperature is at most about room temperature and the treatment temperature is about body temperature. Preferred adjuvants include acids, whitening agents, fluoride, anti-microbial agents, and medicaments.
BRIEF DESCRIPTION OF THE DRAWING
FIG. 1 is a graphic illustration of the viscosity versus temperature data as described in Example 1.
FIG. 2 is a graphic illustration of the viscosity versus temperature data as described in Example 7.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The present invention provides a dental composition in a low viscosity state prior to application onto an oral surface, but which also is highly viscous, thick and controllable at the target site. These compositions are easily dispensed, applied, and manipulated when handled by the user, and are easily controlled upon application to the target site. Because the composition has a low viscosity initially at a pre-treatment temperature, it requires lower syringe extrusion forces to deliver the compositions to the intended site. In turn, this would allow a user the alternative of using a brush or other applicator to apply the composition. In addition, production of low viscosity compositions may provide easier processing and greater uniformity and consistency.
Compositions of this invention are particularly suitable for use in the intraoral environment where a composition having a pre-treatment temperature at or lower than ambient (room temperature) is applied to a user's oral surface that is near or at oral temperature of about 30° C. to about 39° C. For certain dental applications, it is preferred that the composition be thermally reversible. In that application, the composition not only has the ability to increase its viscosity at an elevated intra-oral temperature, but also reverses or decreases its viscosity upon a decrease in temperature.
The capacity of the dental composition to thicken at oral temperatures is a critical feature of the invention, for it is in this property that many of the disadvantages of previous approaches are overcome. The dissipative characteristic of liquid solutions is avoided since the compositions herein experience thickening at the site of treatment. Moreover, the problems of formulation, handling, delivery and application of viscous compositions are overcome since the present compositions may be free-flowing liquids prior to treatment.
For example, the art of etching hard tissue typically requires etching a target site or controlled areas of several teeth at one time. Current etchant liquids are easy to dispense and apply, but these tend to flow away from the target area of application. Consequently, an etch patch could be larger than desired or, more undesirably, contact with the soft tissue could occur, which can cause sensitivity or irritation. A large etch patch unnecessarily increases the risk of decalcification during treatment. Some compositions have been provided in thickened states to provide less flow and mobility; however, they are often difficult to dispense.
Furthermore, other applications, such as dental whitening, suffer when the dental whitening compositions decrease in viscosity due to the increase in temperature from the intraoral environment. This thinning and viscosity decrease creates a tendency for the whitening composition to flow from the target location, resulting in a reduced amount of whitening composition available for treatment at the target location for the desired length of time.
A “semi-solid,” as used herein, is a material whose physical state is between the solid and liquid state, in which pure or mixed solvent or solution is entrained within a network, and can alternatively be considered a gel. By “pure or mixed solvent and/or solution,” as stated herein, it is recognized that a mixture of solvents may be absorbed by the network. Additionally, the solvent may include salts or other additives so as to form a solution, which may also be absorbed or entrained within the network.
“Thickening” as used herein, is where a composition undergoes a substantial increase in the viscosity of the composition. The degree of thickening is dependent on the initial viscosity of the composition.
In a preferred embodiment of the invention, the initial viscosity of the composition may be low enough such that the composition is in a liquid state. Subsequently, upon exposure to a temperature of about near or at oral temperature, the viscosity increases to result in a thickened composition. A viscosity increase in the range of about 10- to about 100-fold can be experienced when the initial viscosity is such that the composition is a liquid. Thus, for example, a composition in a liquid state may have a viscosity of about 0 to about 7000 poise. In response to an increase in temperature, the viscosity of the composition can increase to at least about 10,000 poise. Upon the lowering of the temperature, the composition preferably has the ability to reverse its viscosity and return to flow properties of a liquid.
Yet another preferred embodiment of the invention is when the initial viscosity of the composition is at a level at which the composition is in a semi-solid state at pre-treatment temperature (viscosity is at least about 5000 poise), and upon exposure to a higher treatment temperature, the composition transforms into an “ultra-thick” composition or one with a substantially higher viscosity and very low flow characteristics. For compositions having initially high viscosities, the degree of thickening is typically about 2- to about 5-fold.
The pre-treatment temperature is the temperature at which the composition is subjected to prior to application or treatment. The range for the pre-treatment temperature can be about 5° C. to about 29° C., although there may be certain instances where the temperature may be outside this range. Having a pre-treatment temperature at about 20° C. to about 25° C. allows the composition to be easily stored at ambient or room temperature. Alternatively, the compositions of the invention can also be advantageously stored at lower, refrigeration pre-treatment temperatures of about 5° C. to about 10° C. to provide improved stability and shelf life.
The treatment temperature is the temperature at which the composition is exposed during intraoral application. This can be at or near body temperature, or about 30° C. to about 39° C.
In accordance with the invention, the dental composition consists of a water-miscible, physiologically compatible medium that is liquid at ambient temperature below about 30° C. and experiences thickening at oral temperatures above about 30° C. It has been found that a composition having a thickening transition temperature in the range of from about 25° C. to about 40° C. is useful in the practice of the present invention. Preferably, the thickening occurs in a temperature range of from about 25° C. to about 39° C., and more preferably from about 30° C. to about 35° C.
Compositions of this invention are comprised of a solvent and one or more polymeric substances that provide the desired viscosity increase at the desired elevated temperature range in the said composition. Optionally, adjuvants may be added to the composition. Preferably, the composition of this invention should be physiologically compatible so that no adverse reaction occurs if the dental composition comes in contact with human tissue or fluids.
As used herein, a “thermally responsive viscosity modifier” is one or more polymeric substances that provide the composition or polymeric system the capability of substantially changing its viscosity in response to a change in temperature. Suitable polymeric substances useful as thermally responsive viscosity modifiers include polyoxyalkylene polymers, particularly the polymeric surfactants available under the tradename PLURONIC. This class of polymers is available commercially from BASF Wyandotte Corporation. Other polyoxyalkylene polymers may also be useful as a thermally-responsive composition material.
A preferred dental composition in accordance with this invention comprises an aqueous solution of a selected polyoxyethylene-polyoxypropylene block copolymer. A composition comprising polyoxyethylene-polyoxypropylene block copolymers in which the number of polyoxyethylene units is at least about 50% of the number of units in the total molecule, and the block copolymer having an average molecular weight of from about 1100 to about 15,500 has been found to be particularly useful. It is more preferable that a composition comprises about 70% polyoxyethylene units of the total number of monomeric units in the copolymer and the copolymer has an average molecular weight of about 11,500. PLURONIC F-127 is a material that meets these criteria.
The PLURONIC polymers are closely related block copolymers that may be generically classified as polyoxypropylene-polyoxyethylene condensates that terminate in primary hydroxyl groups. These polymers are formed by the condensation of propylene oxide into a propylene glycol nucleus followed by the condensation of ethylene oxide onto both ends of the polyoxypropylene base. The polyoxyethylene hydrophilic groups on the ends of the base pre-polymer are controlled in length to constitute from about 10% to about 80% by weight of the final polymer.
The PLURONIC polymer series of products may be represented empirically by the formula: HO(C2H4O)a(C3H6O)b(C2H4O)cH where a and c are statistically equal.
The concentration of the block copolymers is an important parameter and can be formulated in such a manner corresponding to the other components' concentrations. By adjusting the concentration of the copolymer to accommodate other solutes present in the composition, any desired liquid to semi-solid transition temperature in the critical range of above ambient temperature and below body temperature can be achieved. Thus, the principal consideration is the selection of a concentration that, in conjunction with all of the constituents of the total composition, will provide a liquid to semi-solid transition temperature in the required range.
It has been found that a useful block copolymer concentration is from about 5% to about 40% by weight (wt. %) of the composition, particularly from about 15 wt. % to about 26 wt. % of the composition. Excellent results have been obtained using aqueous solutions having from about 17 wt. % to about 29 wt. % of PLURON1C F-127. Increased polymer concentrations may be required in highly acidic systems to affect the same results as in a less acidic system so that, in optimizing the thickening or gelation characteristics for a system, the pH of the solution must be taken into account.
Particularly preferred polymers for the present invention are the PLURONIC F-127 and F-108. These viscosity modifiers are block copolymers of ethylene oxide and propylene oxide. Thickening tendencies of block copolymers increase as ethylene oxide content and total molecular weight increase. Thermally responsive block copolymers have been disclosed in U.S. Pat. Nos. 4,474,751; 4,474,752; 5,441,732; and 5,252,318, as well as the Product Catalog, “BASF Performance Chemicals,” all the teachings of which are incorporated by reference herein. These block copolymers offer extremely low toxicity and a high degree of mildness for applications involving human contact.
A preferred solvent for the composition of this invention is water. The concentration of water in the composition can be in the range of from about 30 wt. % to about 90 wt. % of the composition. Preferably, water can exist in the range of about 40 wt. % to about 80 wt. % of the composition. The water used in forming the aqueous solution is preferably purified, as by distillation, filtration, ion-exchange, or the like.
Co-solvents may be used, including anhydrous solutions comprising a polyol component such as propylene glycol or polyethylene glycol. Glycerin may also be used as a constituent of the composition.
Adjuvants can be added to the composition for various purposes (e.g., acids for dental etchants and whitening agents for dental whiteners). For example, a preferred embodiment of the invention can contain fluoride, a desirable additive in the oral composition. Additives may also be included in the composition to promote the stability of the formulation. Anti-microbial agents, anti-fungal agents, and preservatives may be added to the composition to improve shelf-life. The compositions may further include other adjuvants such as medicaments, indicators, dyes, wetting agents, buffering agents, thixotropes, polyols and the like, contingent upon attainment of the desired degree of etching performance and suitability for use on the desired hard tissue. For example, a composition may contain indicators that communicate to the user the degree of etching that has been performed on the hard tissue. The compositions may further include other adjuvants such as fillers, cariostatic agents and flavorings.
When the dental composition is a dental etchant, acids may be added to the composition as an adjuvant. Acids for use in the present invention can be inorganic or organic acids, and if organic can be monomeric, oligomeric or polymeric. If desired, a precursor to the acid such as an acid anhydride, e.g., 4-Methacryloxyethyl Trimellitate Anhydride (4-META), acid halide (including inorganic acid halides such as Lewis acids, e.g., ferric chloride, and organic acid halides), or ester can be used in place of the acid itself, e.g., to generate the desired acid in situ. Suitable acids include mineral acids, carboxylic acids, sulfonic acids, and phenols, with carboxylic acids, alkylsulfonic acids, arylsulfonic acids, and phosphonic acids being preferred.
The acid has a pKa in water that is less than or equal to that of phenol. Preferably, the pKa of the acid is between about −20 and about +10, more preferably between about −10 and about +5.
The acid can be liquid or a solid; if a solid it should be dissolved in a suitable solvent to enable the acid to wet the hard tissue. Liquid acids can also be dissolved in a suitable solvent, e.g., in order to facilitate wetting. Preferred solvents for the acid are the film former cosolvents discussed in more detail below.
Suitable inorganic acids include hydrobromic acid, hydrochloric acid, nitric acid, phosphoric acid, and sulfuric acid. Suitable organic acids include acetic acid, α-chloropropionic acid, 2-acrylamido-2-methylpropane sulfonic acid, acrylic acid, benzenesulfonic acid, benzoic acid, bromoacetic acid, 10-camphorquinone-sulfonic acid, 10-camphorsulfonic acid, chloroacetic acid, citraconic acid, citric acid, dibromoacetic acid, dichloroacetic acid, di-Hema ester of 1,2,4,5 benzenetetracarboxylic acid, 2,4-dinitrophenol, ethylenediaminetetraacetic acid (EDTA), the mono-, di- and trivalent salts of EDTA, formic acid, fumaric acid, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid, maleic acid, methacrylic acid, 2-naphthalene sulfonic acid, oxalic acid, p-nitrophenol, phenol, phosphorous acid esters (such as 2,2′-bis(a-methacryloxy-b-hydroxypropoxyphenyl) propane diphosphonate (Bis-GMA diphosphonate), dibutyl phosphite, di-2-ethyl-hexyl phosphate, di-2-ethyl-hexyl phosphite, hydroxyethyl methacrylate monophosphate, glyceryl dimethacrylate phosphate, glyceryl-2-phosphate, glycerylphosphoric acid, methacryloxyethyl phosphate, pentaerythritol triacrylate monophosphate, pentaerythritol trimethacrylate monophosphate, dipentaerythritol pentaacrylate monophosphate, and dipentaerythritol pentamethacrylate monophosphate), pivalic acid, propionic acid, toluene sulfonic acid, tribromoacetic acid, trichloroacetic acid, trifluoroacetic acid, trifluoromethanesulfonic acid, and trihydroxybenzoic acid. Mixtures of such acids can be used if desired.
In the practice of the present invention, the hard tissues that can be etched include human and animal tissues such as teeth, including the component parts which are enamel, dentin, and cementum. The invention has particular utility for etching dentin, sclerotic dentin, enamel, and cervical enamel. In a preferred method of the invention, the etchant is permitted to stand on the hard tissue for a desired period of time, readily volatile cosolvents are removed therefrom (e.g., by air-drying) to modify the surface of the hard tissue. Delivery of the etching composition of the invention may be performed in various methods. One method of delivery of the etching composition is the direct application of the composition onto the hard tissue. This may be done directly from the composition's container or dispenser such as a bottle, vial, syringe, or tube. Alternatively, it can be applied by using a brush to paint or coat the composition onto the hard tissue. The composition is kept on the hard tissue for a desired period to effectuate etching. The length of time the composition is in contact with the hard tissue would depend on the amount of etching desired.
A preferred method of use comprises first etching with the composition of the present invention, followed by an application of a dental material on the tissue such as a sealant or coating, restorative material, adhesive, cement, dental primer or film former. Yet another preferred method is first etching with the composition of the present invention, then followed by an application of a bonding agent for purposes of bonding an orthodontic appliance onto a tooth. The invention enables etching of hard tissue in order to improve the bond strength or durability of a restorative or coating applied thereto.
Hard tissue to which the etchant is applied preferably is first cleaned using conventional methods (e.g., by abrading it with a bur), rinsed (e.g., using water) and dried (e.g., using air). If desired, deep excavations in teeth can be lined with a conventional basing material, (e.g., calcium hydroxide or a glass ionomer cement).
The acid should be allowed to stand on the surface of the hard tissue long enough to provide the desired degree of etching. The standing time will depend upon the particular acid employed, the type of hard tissue and its intended use, and the time available for carrying out the etching procedure. For etching dentin and enamel, standing times less than about 5 minutes, and preferably about 5 seconds to one minute provide very effective etching, although shorter or longer times can be used if desired.
When the dental composition is a dental whitener, whitening agents may be added to the composition as an adjuvant. The whitening agent used in the present invention may be any material that has the effect of whitening teeth. Whitening agents are preferably selected from hydrogen peroxide and its urea complex: carbamide peroxide (CO (NH2)2H2O2). These whitening agents are also known by alternative names, including urea hydrogen peroxide, hydrogen peroxide carbamide, or perhydrol-urea. Alternatively, sodium hypochlorite may be suitable for use as the whitening agent. The concentration of a whitening agent in the composition can vary depending upon its reactivity. With carbamide peroxide, for example, the currently preferred concentration range is from about 3% to about 40%, with a range from about 4% to about 21% being most preferred. In the case of hydrogen peroxide, which is more reactive than carbamide peroxide, the currently preferred concentration range is from about 2% to about 10%.
Various methods can be employed in using the whitening composition of this invention. One method of use of these whitening compositions entails application of the composition to the tooth structure directly from the composition's container or dispenser such as a bottle, syringe, or tube. Alternatively, the whitening composition can be applied by using a brush to paint it onto the tooth surface. The composition is kept on the user's tooth surface(s) for a desired time period to effectuate whitening. The length of time the composition is in contact with the tooth surface(s) would depend on the amount of discoloration the user prefers to remove.
In a preferred method, the whitening composition is loaded into a dental tray. Such dental trays can be custom fitted to a user's dentition and be made with or without reservoirs. A preferred reservoir is described in U.S. Pat. No. 6,126,443. Dental trays can be made from varying thicknesses and softness of pliable thermo-formable plastic materials. Typically, these materials are 0.02-0.08 inches thick. After dispensing or loading the whitening composition into the dental tray, the user then places the loaded tray into the mouth and initiates thickening of the composition. The thickening occurs when the composition is exposed to the elevated treatment temperature of the oral environment. The tray is retained in the mouth to effectuate whitening of the tooth surface(s) for a sufficient period of time to remove discoloration.
An alternative method of use incorporates a pre-warmed dental tray into which the whitening composition is loaded. Upon contact of the composition having a pre-treatment temperature, with the tray having a higher temperature, the composition experiences thickening. This method provides easy handling of a loaded tray into a user's mouth, with minimal fear of the composition moving to an undesired section of the tray or having the composition flow out of the tray. Where the dental compositions are thermally reversible, the composition can be readily removed from the hard tissue by cooling the material below the liquid to semi-solid transition temperature, thus reversing the thickening effect. This can be accomplished with cool water or other physiologically compatible liquid. Alternatively, the concentrations of the components in the composition may be adjusted and diluted by adding water or other liquid solution. By adjusting the concentrations of the components, the transition temperature is correspondingly adjusted, and thus provides the user the ability to remove the composition even with warm solutions. Water or other liquid solutions may be administered through a rinsing cup, squirt bottle, a liquid dispensing dental tool, or any other liquid dispensing device that can provide solution to the oral environment. Preferably, administering cool or cold water provides a significant decrease in viscosity. Alternatively, the composition may be brushed, wiped, or blown off.
These and other aspects of the invention are illustrated by the following examples that should not be viewed as limiting in scope. Unless otherwise indicated, all molecular weights are number average molecular weights and all ratios, parts and percentages are by weight.
EXAMPLES Example 1
Etching compositions were made in which the acid used was 3M Etchant Liquid manufactured by 3M Dental Products Division. Sample compositions 2 through 7 were mixed such that the compositions contained 15-30% by weight of PLURONIC F127 (BASF) in 3M Etchant Liquid (3M Co., St. Paul, Minn.).
Complex viscosity versus temperature data were obtained using a controlled strain rheometer (“RDA2”, Rheometrics Scientific, Piscataway, N.J.). A parallel plate geometry was used with a plate diameter of 25 mm and a gap of approximately 1 mm. Samples were subjected to an oscillatory strain of 10% applied at a frequency of 1 rad/sec while the temperature was ramped from 15° to 45° C. (3° C./min). The resulting data is shown in FIG. 1.
The compositions 1-7 are phosphoric acid gels of the following types:
  • Composition #
  • Comparative 1 3M Dental Etchant Gel containing fumed silica (3M Co.)
  • Comparative 2 Contains 15.3% PLURONIC F127+84.7% 3M Etchant Liquid
  • Comparative 3 Contains 18.4% PLURONIC F127+81.6% 3M Etchant Liquid
  • Comparative 4 Contains 21.3% PLURONIC F127+78.7% 3M Etchant Liquid
  • Comparative 5 Contains 24.0% PLURONIC F127+76% 3M Etchant Liquid
  • Comparative 6 Contains 26.5% PLURONIC F127+73.5% 3M Etchant Liquid
  • Comparative 7 Contains 28.8% PLURONIC F127+71.2% 3M Etchant Liquid
    FIG. 1 illustrates the viscosity of each composition in response to temperature. As seen in the Figure, the liquid to gel transition temperature for the compositions containing PLURONIC, as shown by the substantial increase in viscosity in response to temperature increases, is dependent on the concentration of the PLURONIC block copolymer. The silica filled etchant (Comparative Composition 1) maintained a high, consistent viscosity throughout the temperature range.
Example 2
Compositions 2 and 7 were further tested using a laboratory convection oven, heated to a temperature of approximately 45° C.
The concentration of PLURON1C F127 had significant impact on the initial viscosity of the acid etchant gel as well as the temperature at which the acid formed an “immobile gel.” An “immobile gel” indicates that the gel did not flow readily under its own weight in small volumes but was still able to be easily manipulated into new positions using hand-held dental instruments. The composition that contained 15.3% PLURONIC F127 had a low initial viscosity similar to that of 3M Etchant Liquid and did not form an immobile gel at approximately body temperature but did form an immobile gel at approximately 45° C. The composition containing 28.8% PLURONIC F127 was a thick liquid when cooled in a refrigerator at approximately 5° C., but was an immobile gel at room temperature of approximately 24° C.
Example 3
An acid composition (gel) containing 24% PLURONIC F127 and 76% 3M Etchant Liquid was placed on a bovine tooth heated to 37° C. The gel was extruded from a syringe as a liquid but formed an immobile gel on contact with the tooth. The gel was left in place for 30 seconds, washed with cold water and dried in the air. There was an obvious difference between the etched and unetched surfaces indicating that the acid gel was effective.
Example 4
An acid gel containing 19.4% PLURONIC F127, 8.1% citric acid (Aldrich, Milwaukee, Wis.) and 72.5% DI water was placed on a bovine tooth heated to 37° C. The gel was extruded from a bottle as a liquid but formed an immobile gel on contact with the tooth. The gel was left in place for 45 seconds, washed with cold water and air dried. There was an obvious difference between the etched and unetched surfaces indicating that the acid gel was effective.
The citric acid and phosphoric acid gels had similar initial viscosity and gel characteristics with significantly different levels of PLURONIC F127. More PLURONIC F127 is required in highly acidic systems to affect the same results as in a less acidic system so that, in optimizing the gelation characteristics for a system, pH of the stock etchant solution must be taken into account.
Preparation of Stock Solution 1
An aqueous stock solution containing approximately 15% hydrogen peroxide (H2O2) was prepared by transferring 5 grams of a 30% H2O2 (J. T. Baker) and 5 grams of distilled water to a glass vial. The stock solution was mixed thoroughly.
Preparation of Stock Solution 2
An aqueous stock solution containing approximately 20% urea hydrogen peroxide (carbamide peroxide) was prepared by transferring 4 grams of 97% urea hydrogen peroxide (Sigma) and 16 grams of distilled water to a glass vial. The stock solution was mixed thoroughly. (The hydrogen peroxide content of the urea hydrogen peroxide was about 35%). Stock solution contained about 7% H2O2.
Example 5
A thermally-reversible hydrogen peroxide composition was prepared by transferring the ingredients below to a glass vial and mixing thoroughly until a colorless and transparent liquid solution was obtained.
Stock Solution 1 1.60 grams
PLURONIC F127 (BASF) 0.40 grams
2.00 grams

The above solution contained approximately 12% hydrogen peroxide, 68% water and 20% PLURONIC F127. The glass vial containing the liquid peroxide solution was warmed to body temperature by holding the vial in a human hand. Following about one to two minutes, the liquid was transformed into a colorless, transparent composition that did not flow upon inverting the vial. The vial was allowed to cool to room temperature wherein the composition was transformed back to the low viscosity state. This cycle was repeated several limes with the same outcome.
The liquid and semi-solid (gel) states were both semi-quantitatively evaluated for hydrogen peroxide utilizing hydrogen peroxide analysis strips. The analysis utilized “EM Quant Peroxide Test Strips” (EM Science Gibbstown, N.J., Catalog No. 10011-1). The compositions were evaluated according to the manufacturer's directions.
Results of the tests indicated that both the liquid and semi-solid states contained significant amounts of available peroxide.
The same sample was re-evaluated 2 months later and found to still exhibit thermally-reversible characteristics and comparable hydrogen peroxide levels based on the semi-quantitative analysis.
Example 6
A thermally reversible composition containing urea hydrogen peroxide was prepared by transferring the ingredients below to a glass vial and mixing thoroughly until a colorless and transparent liquid solution was obtained.
Stock Solution 2 4.00 grams
PLURONIC F127 (BASF) 1.00 grams
5.00 grams

The above solution contained approximately 16% urea hydrogen peroxide (or about 5.6% hydrogen peroxide), 64% water and 20% PLURONIC F127. The glass vial containing the liquid peroxide solution was warmed to body temperature by holding the vial in a human hand. After about 1 minute, the liquid transformed to a colorless, transparent composition that did not flow upon inverting the vial. The vial was allowed to cool to room temperature wherein the semi-solid composition was transformed back to the low viscosity state. This cycle was repeated several times with the same outcome.
The liquid and semi-solid states were both semi-quantitatively evaluated for hydrogen peroxide utilizing hydrogen peroxide analysis strips, EM Quant Peroxide Test Strips (EM Science; Gibbstown, N.J., Catalog No. 10011-1), according to the manufacturer's directions. Both the liquid and semi-solid states indicated the presence of significant amounts of available peroxide.
The same sample was re-evaluated 9 days later and found to still exhibit thermally-reversible characteristics and comparable hydrogen peroxide levels based on the semi-quantitative analysis.
Table 1 summarizes the results of the two previous examples. The “+” indicates an increase in the viscosity. The indicates a decrease in the viscosity. The presence of hydrogen peroxide as indicated in the table are the results obtained from the semi-quantitative test using the EM Quant Peroxide Test Strips and test method.
TABLE 1
H2O2
35° C. 25° C. Present
%
35° C. viscosity 25° C. viscosity H2O2 @ 9
Peroxide viscosity @ 9 days viscosity @ 9 days Present days
Example 5 12 + + Yes Yes
Example 6 16 + + Yes Yes
Example 7
Several compositions have been evaluated for viscosity as a function of temperature. The compositions are described below:
TABLE 2
Comparative Sample A
Physical Physical
parts by % by Appearance Appearance
Component weight (g) weight at 23° C. at body temp
Urea
20 20 Low viscosity, Low viscosity,
hydrogen colorless liquid Colorless liquid
peroxide
Water 80 80
TABLE 3
Sample B
Physical Physical
Parts by % by Appearance at Appearance at
Component weight (g) weight 23° C. Body temp
Urea
20 16 Low viscosity, non-flowing,
hydrogen Colorless liquid colorless gel
peroxide
Water 80 64
PLURONIC 25 20
F-127
TABLE 4
Sample C
Physical Physical
Parts by % by Appearance at Appearance at
Component weight (g) weight 23° C. Body temp
Urea 1.6 14.7 Non-flowing, Non-flowing,
hydrogen colorless gel colorless gel
peroxide
Water 6.4 58.7
PLURONIC 2.0 18.3
F-127
CAB-O-SIL 0.9 8.3
M-5* (fumed
silica)
*available from Cabot Corp. (Boston, MA)
Samples were further evaluated for viscosity as a function of temperature between 15° C. and 45° C. utilizing a Rheometrics RDA II Rheometer. Complex viscosity, η* (units of measure is in Poise), versus temperature data were obtained using a controlled strain rheometer (“RDA2”, Rheometrics Scientific, Piscataway, N.J.). A parallel plate geometry was used with a plate diameter of 25 mm and a gap of approximately 1 mm. Samples were subjected to an oscillatory strain of 10% applied at a frequency of 1 rad/sec while the temperature was ramped from 15° C. and 45° C. (3° C./min).
Set out below is the RDA viscosity data. FIG. 2 illustrates that aqueous compositions containing PLURONIC F127 polymer exhibit a relatively sharp increase in viscosity upon warming from room temperature to about 45° C. Sample C, which exhibited semi-solid-like characteristics at room temperature (due to the incorporation of a fumed silica), also increased substantially upon an increase in temperature.
TABLE 5
A B C
Temp η° Temp η° Temp η°
° C. P ° C. P ° C. P
14.02 9.75424 17.88 2308.56 18.5 52951.1
14.28 3.35258 17.88 2379.72 18.3 42757.9
15.36 7.33292 18.54 2587.46 18.79 41559.9
17.28 3.46242 19.42 3111.41 19.64 41144.7
19.46 5.85152 20.91 3711.59 20.76 41347.4
21.12 5.79953 22.36 4580.71 22.09 42047
22.89 7.09599 23.72 5661.42 23.51 43615.7
24.91 4.19887 25.46 7221.65 24.04 45494.3
26.31 0.87001 26.85 8940.38 26.03 48768.7
28.23 3.13629 28.73 25375.6 27.94 55250.6
30.12 4.57411 30.7 29698.2 29.57 82062.6
31.6 4.7215 32.07 33651.8 31.31 94988.5
33.2 9.01765 33.57 37181.2 32.83 1.04E + 05
35.02 8.0025 35.22 40557.8 34.36 1.09E + 05
36.75 2.94618 36.89 43766.3 36.09 1.13E + 05
38.44 4.24626 38.43 46677.4 37.49 1.20E + 05
40.85 1.08273 40.01 49322.7 38.95 1.26E + 05
42.92 5.04081 41.84 52296.6 40.7 1.32E + 05
43.52 54490.4 42.2 1.36E + 05
43.9 1.39E + 05

Claims (37)

1. A method of applying a dental composition in the oral environment to a tooth structure using an aqueous dental composition comprising about 10% by weight to about 50% by weight of a thermally responsive viscosity modifier one or more polymers, water, and an one or more adjuvants, wherein the composition is in one or more polymers is a polyoxyalkylene polymer, which provides the composition with a lower viscosity state at a pre-treatment temperature and a highly viscous higher viscosity state at a treatment temperature that is higher than the pre-treatment temperature, comprising:
applying the composition through an orifice onto a surface of the tooth structure, wherein the composition is at the pretreatment temperature and in the lower viscosity state prior to being applied onto the surface of the tooth structure,
allowing the composition to warm to the treatment temperature and increase in viscosity to the highly viscous higher viscosity state wherein the viscosity of the composition at the treatment temperature is at least about 10 times the viscosity of the composition at the pre-treatment temperature, and
allowing the composition to remain on the surface of the tooth structure.
2. The method of claim 1 wherein the pre-treatment temperature is at most about room temperature.
3. The method of claim 1 wherein the treatment temperature is about body temperature.
4. The method of claim 1 wherein the thermally responsive viscosity modifier is a polyoxyalkylene polymer.
5. The method of claim 1 wherein the composition further comprises a solvent.
6. The method of claim 1 wherein the viscosity of the composition at the treatment temperature is about 10 times to about 100 times the viscosity of the composition at the pre-treatment temperature.
7. The method of claim 1 wherein the composition decreases in viscosity upon cooling from the treatment temperature.
8. The method of claim 7 further comprising removing the composition from the surface by cooling the composition from the treatment temperature.
9. The method of claim 8 wherein the composition is cooled by application of a cool liquid.
10. The method of claim 9 wherein the liquid comprises water.
11. The method of claim 1 wherein applying the composition onto a surface comprises applying the composition onto hard tissue.
12. The method of claim 1 wherein applying the composition through an orifice comprises applying the composition through an orifice of a syringe.
13. The method of claim 1, wherein the dental composition comprises about 17% by weight to about 40% by weight of a thermally responsive viscosity modifier the one or more polymers.
14. The method of claim 1, wherein the adjuvant is selected from the group consisting of acids and medicaments.
15. The method of claim 1, wherein the adjuvant is selected from the group consisting of whitening agents and medicaments.
16. A method of applying a dental composition in the oral environment to a tooth structure using an aqueous dental composition comprising about 10% by weight to about 50% by weight of a thermally responsive viscosity modifier one or more polymers, water, and an one or more adjuvants selected from the group consisting of fluoride, anti-microbial agents, anti-fungal agents, and cariostatic agents, wherein the composition is in one or more polymers is a polyoxyalkylene polymer, which provides the composition with a lower viscosity state at a pre-treatment temperature and a highly viscous higher viscosity state at a treatment temperature that is higher than the pre-treatment temperature, comprising:
applying the composition through an orifice onto a surface of the tooth structure, wherein the composition is at the pretreatment temperature and in the lower viscosity state prior to being applied onto the surface of the tooth structure,
allowing the composition to warm to the treatment temperature and increase in viscosity to the highly viscous higher viscosity state wherein the viscosity of the composition at the treatment temperature is at least about 10 times the viscosity of the composition at the pre-treatment temperature, and
allowing the composition to remain on the surface of the tooth structure.
17. The method of claim 1, wherein the aqueous composition includes a salt.
18. A method of applying a dental composition to a tooth structure using an aqueous dental composition comprising about 10% by weight to about 50 % by weight of one or more polymers, water, and one or more adjuvants, wherein the one or more polymers is a polyoxyalkylene polymer, which provides the composition with a lower viscosity state at a pre-treatment temperature and a higher viscosity state at a treatment temperature that is higher than the pre-treatment temperature, comprising:
applying the composition through an orifice onto a surface of the tooth structure, wherein the composition is at the pretreatment temperature and in the lower viscosity state prior to being applied to the surface of the tooth structure,
allowing the composition to warm to the treatment temperature and increase in viscosity to the higher viscosity state wherein the viscosity of the composition at the treatment temperature is at least about 2 times the viscosity of the composition at the pre-treatment temperature, and
allowing the composition to remain on the surface of the tooth structure.
19. A method of applying a dental composition to a tooth structure using an aqueous dental composition comprising about 10% by weight to about 50 % by weight of one or more polymers, water, and one or more adjuvants, wherein the one or more polymers is a polyoxyalkylene polymer, which provides the composition with a viscosity of about 0 to about 7000 poise at a pre-treatment temperature and a viscosity of at least about 10,000 poise at a treatment temperature that is higher than the pre-treatment temperature, comprising:
applying the composition through an orifice onto a surface of the tooth structure, wherein the composition is at the pretreatment temperature and has a viscosity of about 0 to about 7000 poise prior to being applied to the surface of the tooth structure,
allowing the composition to warm to the treatment temperature and increase in viscosity to at least about 10,000 poise, and
allowing the composition to remain on the surface of the tooth structure.
20. A method of applying a dental composition to a tooth structure using an aqueous dental composition comprising about 10% by weight to about 50 % by weight of one or more polymers, water, and one or more adjuvants, wherein the one or more polymers is a polyoxyalkylene polymer, which provides the composition with a liquid and lower viscosity state at a pre-treatment temperature and a higher viscosity state at a treatment temperature that is higher than the pre-treatment temperature, comprising:
applying the composition through an orifice onto a surface of the tooth structure, wherein the composition is at the pretreatment temperature and in the liquid and lower viscosity state prior to being applied to the surface of the tooth structure,
allowing the composition to warm to the treatment temperature and increase in viscosity to the higher viscosity state such that the composition forms an immobile gel, and
allowing the composition to remain on the surface of the tooth structure.
21. The method of claims 18, 19, or 20 wherein the pre-treatment temperature is at most about room temperature.
22. The method of claims 18, 19, or 20 wherein the treatment temperature is about body temperature.
23. The method of claims 18, 19, or 20 wherein the composition further comprises a solvent.
24. The method of claims 18, 19, or 20 wherein the viscosity of the composition at the treatment temperature is about 10 times to about 100 times the viscosity of the composition at the pre-treatment temperature.
25. The method of claims 18, 19, or 20 wherein the viscosity of the composition at the treatment temperature is about 2 times to about 5 times the viscosity of the composition at the pre-treatment temperature.
26. The method of claims 18, 19, or 20 wherein the composition decreases in viscosity upon cooling the composition from the treatment temperature.
27. The method of claim 26 further comprising removing the composition from the surface by cooling the composition from the treatment temperature.
28. The method of claim 27 wherein the composition is cooled by application of a cool liquid.
29. The method of claim 28 wherein the liquid comprises water.
30. The method of claims 18, 19, or 20 wherein applying the composition through an orifice comprises applying the composition through an orifice of a syringe.
31. The method of claims 18, 19, or 20, wherein the dental composition comprises about 17% by weight to about 40% by weight of the one or more polymers.
32. The method of claims 18, 19, or 20, wherein the adjuvant is selected from acids and medicaments.
33. The method of claims 18, 19, or 20 wherein the adjuvant is selected from whitening agents and medicaments.
34. The method of claims 18, 19, or 20 wherein the adjuvant is selected from fluoride, anti-microbial agents, anti-fungal agents, and cariostatic agents.
35. The method of claims 18, 19, or 20, wherein the aqueous composition includes a salt.
36. The method of claims 18, 19, or 20 wherein the viscosity of the composition at the pre-treatment temperature is at least about 5000 poise.
37. The method of claims 18 or 20 wherein the viscosity of the composition at the treatment temperature is at least about 10,000 poise.
US11/320,560 1998-11-12 2005-12-29 Dental compositions Expired - Lifetime USRE42024E1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/320,560 USRE42024E1 (en) 1998-11-12 2005-12-29 Dental compositions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/190,717 US6312667B1 (en) 1998-11-12 1998-11-12 Methods of etching hard tissue in the oral environment
US09/190,541 US6312666B1 (en) 1998-11-12 1998-11-12 Methods of whitening teeth
US10/001,139 US6669927B2 (en) 1998-11-12 2001-11-01 Dental compositions
US11/320,560 USRE42024E1 (en) 1998-11-12 2005-12-29 Dental compositions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/001,139 Reissue US6669927B2 (en) 1998-11-12 2001-11-01 Dental compositions

Publications (1)

Publication Number Publication Date
USRE42024E1 true USRE42024E1 (en) 2011-01-11

Family

ID=46278426

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/001,139 Ceased US6669927B2 (en) 1998-11-12 2001-11-01 Dental compositions
US11/320,560 Expired - Lifetime USRE42024E1 (en) 1998-11-12 2005-12-29 Dental compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/001,139 Ceased US6669927B2 (en) 1998-11-12 2001-11-01 Dental compositions

Country Status (1)

Country Link
US (2) US6669927B2 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002210433A1 (en) * 2000-07-26 2002-02-05 The Boots Company Plc Dental compositions
GB0018230D0 (en) * 2000-07-26 2000-09-13 Boots Co Plc Dental compositions
EP1343492B1 (en) * 2000-11-22 2006-02-01 Rxkinetix, Inc. Treatment of mucositis
US6620405B2 (en) * 2001-11-01 2003-09-16 3M Innovative Properties Company Delivery of hydrogel compositions as a fine mist
US20050288387A1 (en) * 2002-08-21 2005-12-29 Li Feng Acrylate dental compositions with improved viscosity and storage odor
US7238122B2 (en) * 2002-08-27 2007-07-03 Acushnet Company Ormocer composites for golf ball components
US6793592B2 (en) 2002-08-27 2004-09-21 Acushnet Company Golf balls comprising glass ionomers, or other hybrid organic/inorganic compositions
US20040206932A1 (en) 2002-12-30 2004-10-21 Abuelyaman Ahmed S. Compositions including polymerizable bisphosphonic acids and methods
US20050002975A1 (en) * 2003-06-06 2005-01-06 Densen Cao Structures and methods for delivering topical compositions
US7452924B2 (en) 2003-08-12 2008-11-18 3M Espe Ag Self-etching emulsion dental compositions and methods
JP2007523063A (en) * 2004-01-21 2007-08-16 スリーエム イノベイティブ プロパティズ カンパニー Dental compositions and kits containing bitter inhibitors and related methods
US7156911B2 (en) 2004-05-17 2007-01-02 3M Innovative Properties Company Dental compositions containing nanofillers and related methods
US7649029B2 (en) 2004-05-17 2010-01-19 3M Innovative Properties Company Dental compositions containing nanozirconia fillers
US8465284B2 (en) 2004-07-08 2013-06-18 3M Innovative Properties Company Dental methods, compositions, and kits including acid-sensitive dyes
CA2575976A1 (en) 2004-08-11 2006-02-23 3M Innovative Properties Company Self-adhesive compositions including a plurality of acidic compounds
US20060034784A1 (en) * 2004-08-12 2006-02-16 The Procter & Gamble Company Oral compositions and systems
US20060204452A1 (en) * 2005-03-10 2006-09-14 Velamakanni Bhaskar V Antimicrobial film-forming dental compositions and methods
US20060205838A1 (en) * 2005-03-10 2006-09-14 Velamakanni Bhaskar V Hardenable antimicrobial dental compositions and methods
US20060228307A1 (en) * 2005-04-08 2006-10-12 Cao Group, Inc. Structures and methods for delivering topical compositions
EP1879542A1 (en) * 2005-05-09 2008-01-23 3M Innovative Properties Company Hardenable dental compositions with low polymerization shrinkage
EP1879543B1 (en) 2005-05-09 2012-11-21 3M Innovative Properties Company Dental compositions containing hybrid monomers
US7495054B2 (en) * 2005-09-19 2009-02-24 3M Innovative Properties Company Curable compositions containing dithiane monomers
US7776940B2 (en) 2005-12-20 2010-08-17 3M Innovative Properties Company Methods for reducing bond strengths, dental compositions, and the use thereof
US8026296B2 (en) 2005-12-20 2011-09-27 3M Innovative Properties Company Dental compositions including a thermally labile component, and the use thereof
US7896650B2 (en) 2005-12-20 2011-03-01 3M Innovative Properties Company Dental compositions including radiation-to-heat converters, and the use thereof
US9539065B2 (en) 2006-10-23 2017-01-10 3M Innovative Properties Company Assemblies, methods, and kits including a compressible material
US20080096150A1 (en) 2006-10-23 2008-04-24 3M Innovative Properties Company Dental articles, methods, and kits including a compressible material
CN101557791B (en) 2006-12-13 2013-05-22 3M创新有限公司 Methods of using a dental composition having an acidic component and a photobleachable dye
US20100021869A1 (en) * 2006-12-28 2010-01-28 Abuelyaman Ahmed S (meth)acryloyl-containing materials, compositions, and methods
JP2011509921A (en) 2007-10-01 2011-03-31 スリーエム イノベイティブ プロパティズ カンパニー Orthodontic composition with polymeric filler
EP2331046A2 (en) * 2008-09-04 2011-06-15 3M Innovative Properties Company Dental composition comprising biphenyl di(meth)acrylate monomer
WO2010039395A2 (en) * 2008-09-30 2010-04-08 3M Innovative Properties Company Orthodontic composition with heat modified minerals
WO2010048067A2 (en) * 2008-10-22 2010-04-29 3M Innovative Properties Company Dental composition comprising biphenyl di(meth)acrylate monomer comprising urethane moieties
WO2011162965A1 (en) 2010-06-24 2011-12-29 3M Innovative Properties Company Aqueous composition suitable for intra-oral scanning methods
US9480540B2 (en) 2010-12-30 2016-11-01 3M Innovative Properties Company Bondable dental assemblies and methods including a compressible material
EP2688508A1 (en) 2011-03-24 2014-01-29 3M Innovative Properties Company Dental adhesive comprising a coated polymeric component
US9365459B2 (en) 2012-03-01 2016-06-14 James R. Glidewell Dental Ceramics, Inc. Method for coloring ceramics via colloidal dispersion
US9512317B2 (en) 2012-03-01 2016-12-06 James R. Glidwell Dental Ceramics, Inc. Method for manufacturing coloring ceramics via colloidal dispersion followed by conventional pressing techniques
US9095403B2 (en) * 2012-10-13 2015-08-04 James R. Glidewell Dental Ceramics, Inc. Dental ceramic coloring liquids

Citations (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639574A (en) 1967-10-25 1972-02-01 Basf Wyandotte Corp Stable hydrogen peroxide gels
US3652420A (en) 1964-07-24 1972-03-28 Peter Strong & Co Inc Cleanser compositons for artificial dentures and methods of preparing the same
US4011309A (en) 1975-01-20 1977-03-08 Marion Laboratories, Inc. Dentifrice composition and method for desensitizing sensitive teeth
US4100271A (en) 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4130501A (en) 1976-09-20 1978-12-19 Fmc Corporation Stable viscous hydrogen peroxide solutions containing a surfactant and a method of preparing the same
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4260597A (en) * 1979-09-04 1981-04-07 Porteous Don D Thermally reversible dental astringent gels
EP0102200A2 (en) 1982-08-02 1984-03-07 JOHNSON & JOHNSON DENTAL PRODUCTS COMPANY Neutral topical sodium fluoride gel
JPS59128330A (en) 1983-01-06 1984-07-24 Kuraray Co Ltd Dental acid treatment
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4537778A (en) 1983-01-03 1985-08-27 Colgate-Palmolive Company Oral preparation
WO1986000813A1 (en) 1984-07-27 1986-02-13 Schering Aktiengesellschaft Pharmaceutical compositions containing gels
GB2170406A (en) 1985-02-04 1986-08-06 Colgate Palmolive Co Oral preparation
US4696757A (en) 1986-06-16 1987-09-29 American Home Products Corporation Stable hydrogen peroxide gels
US4719149A (en) 1986-02-28 1988-01-12 Minnesota Mining And Manufacturing Company Method for priming hard tissue
US4770634A (en) 1986-06-11 1988-09-13 Pellico Michael A Method for treating teeth with foamable fluoride compositions
US4774093A (en) 1985-06-25 1988-09-27 Fmc Corporation Polysaccharide compositions, preparation and uses
US4795527A (en) 1987-12-07 1989-01-03 Howard Cohen Tooth etching
US4839156A (en) 1987-04-17 1989-06-13 Colgate-Palmolive Company Stable hydrogen peroxide dental gel
US4861760A (en) 1985-10-03 1989-08-29 Merck & Co., Inc. Ophthalmological composition of the type which undergoes liquid-gel phase transition
US4888168A (en) 1987-03-02 1989-12-19 American Cyanamid Company Stable ophthalmic preparations containing acetazolamide
US4921626A (en) 1989-08-23 1990-05-01 Automark Corporation Glass etching composition and method of making
US4980152A (en) 1987-08-06 1990-12-25 Marion Laboratories Oral preparation
US5000955A (en) 1988-07-29 1991-03-19 Tyndale Plains-Hunter Ltd. Thermally reversible polyurethane hydrogels and cosmetic, biological and medical uses
WO1991014650A1 (en) 1990-03-22 1991-10-03 Ultradent Products, Inc. Dental compositions and methods for treating teeth surfaces
US5057309A (en) 1986-11-06 1991-10-15 Hill Ira D Oral hygiene preparations
US5057308A (en) 1986-11-06 1991-10-15 Hill Ira D Method of treating the oral cavity with oral hygiene preparations containing active SnF2
US5057310A (en) 1986-11-06 1991-10-15 Hill Ira D Method of manufacturing oral hygiene preparations containing active SnF.sub.
US5059417A (en) 1990-06-26 1991-10-22 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Peroxide gel dentifrice
US5061183A (en) 1989-11-13 1991-10-29 Nicholson James A Acid etch for bonding ceramic orthodontic brackets
US5071637A (en) 1989-10-06 1991-12-10 Pellico Michael A Foamable fluoride compositions and method
US5073363A (en) 1989-10-06 1991-12-17 Pellico Michael A Foamable fluoride gels and method
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
US5078129A (en) 1987-05-01 1992-01-07 Research Foundation Of State University Of New York Device for stimulating salivation
US5122365A (en) 1989-02-15 1992-06-16 Natural White, Inc. Teeth whitener
US5124151A (en) 1990-08-07 1992-06-23 Mediventures Inc. Drug delivery by injection with thermo-irreversible gels
US5171564A (en) 1991-09-13 1992-12-15 Colgate-Palmolive Aqueous tooth whitening dentifrice
EP0535816A2 (en) 1991-09-13 1993-04-07 Colgate-Palmolive Company Abrasive tooth whitening dentifrice of improved stability
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5234342A (en) 1990-03-22 1993-08-10 Ultradent Products, Inc. Sustained release method for treating teeth surfaces
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5256065A (en) 1989-11-13 1993-10-26 Nicholson James A Acid etch for dental treatments
US5256396A (en) 1990-01-24 1993-10-26 Colgate-Palmolive Company Topical composition
US5300295A (en) 1990-05-01 1994-04-05 Mediventures, Inc. Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH
EP0325267B1 (en) 1988-01-22 1994-05-11 Carter-Wallace Inc. Peroxide gel dentifrice compositions
US5340613A (en) 1993-03-12 1994-08-23 Minnesota Mining And Manufacturing Company Process for simultaneously coating multiple layers of thermoreversible organogels and coated articles produced thereby
US5376693A (en) 1990-08-07 1994-12-27 Mediventures Inc. Thermo-irreversible gel corneal contact lens formed in situ
US5376006A (en) 1990-03-22 1994-12-27 Ultradent Products, Inc. Dental bleaching compositions and methods for bleaching teeth surfaces
US5376695A (en) 1989-11-10 1994-12-27 Thor Chemie Gmbh Stabilized aqueous solutions of 3-isothiazolones
US5401495A (en) 1990-10-10 1995-03-28 Natural White, Inc. Teeth whitener
US5409630A (en) 1994-02-03 1995-04-25 Colgate Palmolive Co. Thickened stable acidic microemulsion cleaning composition
WO1995013028A1 (en) 1993-11-12 1995-05-18 Mcgill University Implant assembly
WO1996002577A1 (en) 1994-07-18 1996-02-01 Gel Sciences, Inc. Responsive polymer gel beads
US5492937A (en) 1990-11-22 1996-02-20 Pharmacia Ab Gel-forming liquid carrier composition
WO1996006134A1 (en) 1994-08-19 1996-02-29 Gel Sciences, Inc. Responsive gels for selective removal of a target from an environment and methods therefor
EP0545594B1 (en) 1991-11-22 1996-05-01 Colgate-Palmolive Company Oral composition having improved tooth whitening effect
WO1996025457A1 (en) 1995-02-17 1996-08-22 Gel Sciences, Inc. Gel network containing a reactive material
WO1996028056A1 (en) 1995-03-15 1996-09-19 Gel Sciences, Inc. Conformable structures
US5575652A (en) 1987-01-30 1996-11-19 Colgate Palmolive Company Process for applying antibacterial oral composition to dental implant areas
WO1997000275A2 (en) 1995-06-16 1997-01-03 Gel Sciences, Inc. Responsive polymer networks and methods of their use
EP0758544A2 (en) 1995-08-10 1997-02-19 Sun Medical Co., Ltd. Dental or surgical adhesive and polymerization initiator composition for the same
WO1997011675A1 (en) 1995-09-26 1997-04-03 Colgate-Palmolive Company Stable aqueous abrasive peroxide tooth whitening dentifrice
US5631000A (en) 1996-03-11 1997-05-20 Laclede Professional Products, Inc. Anhydrous tooth whitening gel
US5718886A (en) 1996-03-11 1998-02-17 Laclede Professional Products, Inc. Stabilized anhydrous tooth whitening gel
US5766574A (en) 1995-12-08 1998-06-16 Colgate Palmolive Company Dual component tooth whitening dentifrice
US5766012A (en) 1997-04-28 1998-06-16 Rosenbaum; Michael Dental etchant and process of using
WO1998030494A1 (en) 1997-01-10 1998-07-16 Ultradent Products, Inc. Dental bleaching compositions with high concentration of hydrogen peroxide
US5814304A (en) 1996-08-02 1998-09-29 Colgate Palmolive Company Stable aqueous abrasive peroxide tooth whitening dentifrice
US5819988A (en) 1997-04-01 1998-10-13 Sawhney; Ravi K. Double-barreled syringe with detachable locking mixing tip
US5846570A (en) 1997-06-27 1998-12-08 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stabilized hydrogen peroxide gel compositions
US5847023A (en) 1990-10-26 1998-12-08 Mdv Technologies, Inc. Thermal irreversible gel corneal contact lens formed in situ
US5861148A (en) 1995-01-23 1999-01-19 Smith; Stewart Gregory Ophthalmic compositions and process of using
US5902568A (en) 1997-01-15 1999-05-11 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Method for whitening teeth
US5915967A (en) 1994-11-14 1999-06-29 Mcgill University Implant assembly
US5928628A (en) 1997-10-23 1999-07-27 Pellico; Michael A. Two-component dental bleaching system and method
WO2000028955A1 (en) 1998-11-12 2000-05-25 Minnesota Mining And Manufacturing Company Dental whitening composition
WO2000028946A1 (en) 1998-11-12 2000-05-25 Minnesota Mining And Manufacturing Company Dental etching composition
US6116900A (en) 1997-11-17 2000-09-12 Lumachem, Inc. Binary energizer and peroxide delivery system for dental bleaching
US6126443A (en) 1998-08-13 2000-10-03 3M Innovative Properties Company Medication delivery tray

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002276A2 (en) 1994-07-18 1996-02-01 Gel Sciences, Inc. Novel polymer gel networks and methods of use

Patent Citations (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652420A (en) 1964-07-24 1972-03-28 Peter Strong & Co Inc Cleanser compositons for artificial dentures and methods of preparing the same
US3639574A (en) 1967-10-25 1972-02-01 Basf Wyandotte Corp Stable hydrogen peroxide gels
US4011309A (en) 1975-01-20 1977-03-08 Marion Laboratories, Inc. Dentifrice composition and method for desensitizing sensitive teeth
US4100271A (en) 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
GB1571832A (en) 1976-02-26 1980-07-23 Flow Pharma Inc Medical dressings containing pharmaceutically active material
US4130501A (en) 1976-09-20 1978-12-19 Fmc Corporation Stable viscous hydrogen peroxide solutions containing a surfactant and a method of preparing the same
US4260597A (en) * 1979-09-04 1981-04-07 Porteous Don D Thermally reversible dental astringent gels
EP0102200A2 (en) 1982-08-02 1984-03-07 JOHNSON & JOHNSON DENTAL PRODUCTS COMPANY Neutral topical sodium fluoride gel
US4537778A (en) 1983-01-03 1985-08-27 Colgate-Palmolive Company Oral preparation
JPS59128330A (en) 1983-01-06 1984-07-24 Kuraray Co Ltd Dental acid treatment
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
WO1986000813A1 (en) 1984-07-27 1986-02-13 Schering Aktiengesellschaft Pharmaceutical compositions containing gels
GB2170406A (en) 1985-02-04 1986-08-06 Colgate Palmolive Co Oral preparation
US4774093A (en) 1985-06-25 1988-09-27 Fmc Corporation Polysaccharide compositions, preparation and uses
US4861760A (en) 1985-10-03 1989-08-29 Merck & Co., Inc. Ophthalmological composition of the type which undergoes liquid-gel phase transition
US4719149A (en) 1986-02-28 1988-01-12 Minnesota Mining And Manufacturing Company Method for priming hard tissue
EP0612512A2 (en) 1986-02-28 1994-08-31 Minnesota Mining And Manufacturing Company Use of a composition for the manufacture of a primer for coating dentin
US4770634A (en) 1986-06-11 1988-09-13 Pellico Michael A Method for treating teeth with foamable fluoride compositions
US4696757A (en) 1986-06-16 1987-09-29 American Home Products Corporation Stable hydrogen peroxide gels
US5057310A (en) 1986-11-06 1991-10-15 Hill Ira D Method of manufacturing oral hygiene preparations containing active SnF.sub.
US5057308A (en) 1986-11-06 1991-10-15 Hill Ira D Method of treating the oral cavity with oral hygiene preparations containing active SnF2
US5057309A (en) 1986-11-06 1991-10-15 Hill Ira D Oral hygiene preparations
US5575652A (en) 1987-01-30 1996-11-19 Colgate Palmolive Company Process for applying antibacterial oral composition to dental implant areas
US4888168A (en) 1987-03-02 1989-12-19 American Cyanamid Company Stable ophthalmic preparations containing acetazolamide
US4839156A (en) 1987-04-17 1989-06-13 Colgate-Palmolive Company Stable hydrogen peroxide dental gel
EP0288420B1 (en) 1987-04-17 1992-12-30 Colgate-Palmolive Company Stable hydrogen peroxide dental gel
US5078129A (en) 1987-05-01 1992-01-07 Research Foundation Of State University Of New York Device for stimulating salivation
US4980152A (en) 1987-08-06 1990-12-25 Marion Laboratories Oral preparation
US4795527A (en) 1987-12-07 1989-01-03 Howard Cohen Tooth etching
EP0325267B1 (en) 1988-01-22 1994-05-11 Carter-Wallace Inc. Peroxide gel dentifrice compositions
US5000955A (en) 1988-07-29 1991-03-19 Tyndale Plains-Hunter Ltd. Thermally reversible polyurethane hydrogels and cosmetic, biological and medical uses
US5122365A (en) 1989-02-15 1992-06-16 Natural White, Inc. Teeth whitener
US4921626A (en) 1989-08-23 1990-05-01 Automark Corporation Glass etching composition and method of making
US5073363A (en) 1989-10-06 1991-12-17 Pellico Michael A Foamable fluoride gels and method
US5071637A (en) 1989-10-06 1991-12-10 Pellico Michael A Foamable fluoride compositions and method
US5376695A (en) 1989-11-10 1994-12-27 Thor Chemie Gmbh Stabilized aqueous solutions of 3-isothiazolones
US5061183A (en) 1989-11-13 1991-10-29 Nicholson James A Acid etch for bonding ceramic orthodontic brackets
US5256065A (en) 1989-11-13 1993-10-26 Nicholson James A Acid etch for dental treatments
US5256396A (en) 1990-01-24 1993-10-26 Colgate-Palmolive Company Topical composition
US5376006A (en) 1990-03-22 1994-12-27 Ultradent Products, Inc. Dental bleaching compositions and methods for bleaching teeth surfaces
US5770105A (en) 1990-03-22 1998-06-23 Ultradent Products, Inc. Methods for manufacturing sticky bleaching compositions
US5234342A (en) 1990-03-22 1993-08-10 Ultradent Products, Inc. Sustained release method for treating teeth surfaces
US5725843A (en) 1990-03-22 1998-03-10 Ultradent Products, Inc. Methods for bleaching teeth surfaces
WO1991014650A1 (en) 1990-03-22 1991-10-03 Ultradent Products, Inc. Dental compositions and methods for treating teeth surfaces
US5746598A (en) 1990-03-22 1998-05-05 Ultradent Products, Inc. Dental bleaching compositions including a sticky matrix material
US5098303A (en) 1990-03-22 1992-03-24 Ultradent Products, Inc. Method for bleaching teeth
US5409631A (en) 1990-03-22 1995-04-25 Ultradent Products Dental bleaching compositions and methods for bleaching teeth surfaces
US5300295A (en) 1990-05-01 1994-04-05 Mediventures, Inc. Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH
US5441732A (en) 1990-06-15 1995-08-15 Allergan, Inc. Reversible gelation emulsion compositions and methods of use
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5059417A (en) 1990-06-26 1991-10-22 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Peroxide gel dentifrice
US5124151A (en) 1990-08-07 1992-06-23 Mediventures Inc. Drug delivery by injection with thermo-irreversible gels
US5376693A (en) 1990-08-07 1994-12-27 Mediventures Inc. Thermo-irreversible gel corneal contact lens formed in situ
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
US5401495A (en) 1990-10-10 1995-03-28 Natural White, Inc. Teeth whitener
US5847023A (en) 1990-10-26 1998-12-08 Mdv Technologies, Inc. Thermal irreversible gel corneal contact lens formed in situ
US5492937A (en) 1990-11-22 1996-02-20 Pharmacia Ab Gel-forming liquid carrier composition
US5171564A (en) 1991-09-13 1992-12-15 Colgate-Palmolive Aqueous tooth whitening dentifrice
EP0535816A2 (en) 1991-09-13 1993-04-07 Colgate-Palmolive Company Abrasive tooth whitening dentifrice of improved stability
EP0545594B1 (en) 1991-11-22 1996-05-01 Colgate-Palmolive Company Oral composition having improved tooth whitening effect
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5378542A (en) 1993-03-12 1995-01-03 Minnesota Mining And Manufacturing Company Process for simultaneously coating multiple layers of thermoreversible organogels and coated articles produced thereby
US5340613A (en) 1993-03-12 1994-08-23 Minnesota Mining And Manufacturing Company Process for simultaneously coating multiple layers of thermoreversible organogels and coated articles produced thereby
WO1995013028A1 (en) 1993-11-12 1995-05-18 Mcgill University Implant assembly
US5409630A (en) 1994-02-03 1995-04-25 Colgate Palmolive Co. Thickened stable acidic microemulsion cleaning composition
WO1996002577A1 (en) 1994-07-18 1996-02-01 Gel Sciences, Inc. Responsive polymer gel beads
WO1996006134A1 (en) 1994-08-19 1996-02-29 Gel Sciences, Inc. Responsive gels for selective removal of a target from an environment and methods therefor
US5915967A (en) 1994-11-14 1999-06-29 Mcgill University Implant assembly
US5861148A (en) 1995-01-23 1999-01-19 Smith; Stewart Gregory Ophthalmic compositions and process of using
WO1996025457A1 (en) 1995-02-17 1996-08-22 Gel Sciences, Inc. Gel network containing a reactive material
WO1996028056A1 (en) 1995-03-15 1996-09-19 Gel Sciences, Inc. Conformable structures
WO1997000275A2 (en) 1995-06-16 1997-01-03 Gel Sciences, Inc. Responsive polymer networks and methods of their use
EP0758544A2 (en) 1995-08-10 1997-02-19 Sun Medical Co., Ltd. Dental or surgical adhesive and polymerization initiator composition for the same
WO1997011675A1 (en) 1995-09-26 1997-04-03 Colgate-Palmolive Company Stable aqueous abrasive peroxide tooth whitening dentifrice
US5851514A (en) 1995-09-26 1998-12-22 Colgate Palmolive Company Stable aqueous abrasive peroxide tooth whitening dentifrice
US5766574A (en) 1995-12-08 1998-06-16 Colgate Palmolive Company Dual component tooth whitening dentifrice
US5631000A (en) 1996-03-11 1997-05-20 Laclede Professional Products, Inc. Anhydrous tooth whitening gel
US5718886A (en) 1996-03-11 1998-02-17 Laclede Professional Products, Inc. Stabilized anhydrous tooth whitening gel
US5814304A (en) 1996-08-02 1998-09-29 Colgate Palmolive Company Stable aqueous abrasive peroxide tooth whitening dentifrice
WO1998030494A1 (en) 1997-01-10 1998-07-16 Ultradent Products, Inc. Dental bleaching compositions with high concentration of hydrogen peroxide
US5902568A (en) 1997-01-15 1999-05-11 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Method for whitening teeth
US5819988A (en) 1997-04-01 1998-10-13 Sawhney; Ravi K. Double-barreled syringe with detachable locking mixing tip
US5766012A (en) 1997-04-28 1998-06-16 Rosenbaum; Michael Dental etchant and process of using
US5846570A (en) 1997-06-27 1998-12-08 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stabilized hydrogen peroxide gel compositions
US5928628A (en) 1997-10-23 1999-07-27 Pellico; Michael A. Two-component dental bleaching system and method
US6116900A (en) 1997-11-17 2000-09-12 Lumachem, Inc. Binary energizer and peroxide delivery system for dental bleaching
US6126443A (en) 1998-08-13 2000-10-03 3M Innovative Properties Company Medication delivery tray
WO2000028955A1 (en) 1998-11-12 2000-05-25 Minnesota Mining And Manufacturing Company Dental whitening composition
WO2000028946A1 (en) 1998-11-12 2000-05-25 Minnesota Mining And Manufacturing Company Dental etching composition
US6312666B1 (en) 1998-11-12 2001-11-06 3M Innovative Properties Company Methods of whitening teeth
US6312667B1 (en) 1998-11-12 2001-11-06 3M Innovative Properties Company Methods of etching hard tissue in the oral environment

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
"Buyer's Guide to Whitening Systems," Dentistry Today, pp. 125-134 (Dec. 1997).
"Discuss Dental product information sheets for Professional Whitening Products," [on-line]. Discuss Dental [retrieved on Mar. 13, 2000]. Retrieved from the Internet: ;13 pgs.
"Discuss Dental product information sheets for Professional Whitening Products," [on-line]. Discuss Dental [retrieved on Mar. 13, 2000]. Retrieved from the Internet: <URL:http://www.discusdental.com/>;13 pgs.
"Surfactants, Pluronic & Tetronic," BASF product information brochure, Mount Olive, NJ, 40 pages (1999).
"The Innovative Company Behind Rembrandt Products," product information sheets [on-line]. Den-Mat Corporation, Santa Maria, CA, 1998-1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet:<URL:http://www.rembrandt.com/denmat/about.htm>14 pgs, (2004).
"The Innovative Company Behind Rembrandt Products," product information sheets [on-line]. Den-Mat Corporation, Santa Maria, CA, 1998-1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet:14 pgs, (2004).
"Timoptic-XE® (Timolol Maleate Ophthalmic Gel Forming Solution)," product literature (instructions for use), Merck & Co., Inc., West Point, PA, issued Jun. 1999. 6 pgs.
"Ultradent Online Materials and Procedures Manual," [on-line]. Ultradent Products, Inc., 1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet ; 20 pgs.
"Ultradent Online Materials and Procedures Manual," [on-line]. Ultradent Products, Inc., 1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet <URL:http://www.ultradent.com/>; 20 pgs.
BASF Product Literature, "BASF Performance Chemicals Pluronic® & Tetronic® Surfactants," BASF Corporation (1996).
Den-Mat, product information sheets [on-line]. Den-Mat Corporation, Santa Maria, CA, 1998-1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet: ; 10 pgs.
Den-Mat, product information sheets [on-line]. Den-Mat Corporation, Santa Maria, CA, 1998-1999 [retrieved on Mar. 13, 2000]. Retrieved from the Internet: <URL:http://www.denmat.com/main/htm>; 10 pgs.
Haywood, et al., "Nightguard Vital Bleaching," Quintessence International, vol. 20, No. 3, pp. 173-176 (1989).

Also Published As

Publication number Publication date
US20020081269A1 (en) 2002-06-27
US6669927B2 (en) 2003-12-30

Similar Documents

Publication Publication Date Title
USRE42024E1 (en) Dental compositions
US6312667B1 (en) Methods of etching hard tissue in the oral environment
US6312666B1 (en) Methods of whitening teeth
JP4668623B2 (en) Curable thermoresponsive composition
CA2462826C (en) Delivery of hydrogel compositions as a fine mist
Owens et al. Marginal permeability of self-etch and total-etch adhesive systems
LT3816B (en) Composition of priming hard tissue of tooth
US20080299520A1 (en) Foamable Dental Compositions and Methods
AU2002337726A1 (en) Delivery of hydrogel compositions as a fine mist
JP2009522285A (en) Method for applying dental agents to dental surfaces and polymer compositions
CN105530999A (en) Oral compositions, dental structures and methods of delivering oral compositions
JP2001524113A (en) Dental antibacterial material containing 2,4,4&#39;-trichloro-2&#39;-hydroxydiphenyl ether
CN108289801A (en) Oral care gels
JP2020533323A (en) Aqueous Oral Care Fluoride Treatment Compositions and Methods
JP2020535166A (en) Aqueous Oral Care Fluoride Treatment Compositions and Methods
Tung et al. Use of a compomer in Class V restoration: a microleakage study.
WO2009140334A2 (en) Foamable compositions for dental coatings and methods
Mohamed et al. A Comparative study in penetration depth of resin-based materials into white spot lesion
Mofidi et al. Comparison of Microleakage of a Self-adhesive Composite with a Conventional Flowable Composite and Resin Modified Glass Ionomer Cement in Class V Restorations.
JP4712164B2 (en) Dental resin separator composition
WO2023194819A1 (en) Oral care compositions, methods, and kits
EP4065067A1 (en) Oral care composition with cholic acid components for treating caries
Al-Sheed Microleakage of Dyract AP compomers in class V preprations of deciduous teeth after air-dried versus not dried salivary contamination at the occlusal wall (in vitro study)

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

REMI Maintenance fee reminder mailed
FPAY Fee payment

Year of fee payment: 8

SULP Surcharge for late payment

Year of fee payment: 7

FPAY Fee payment

Year of fee payment: 12